Literature DB >> 20802295

Pandemic influenza A (H1N1) in HIV-1-infected patients.

Carlos M Perez1, Maria I Dominguez, Maria E Ceballos, Cristina Moreno, Jaime A Labarca, Ricardo Rabagliati, Patricia Vasquez, Martin Lasso, Michel Serri.   

Abstract

OBJECTIVE: To characterize the clinical presentation, course and mortality of pandemic influenza in HIV-1-infected patients in Santiago, Chile.
METHODS: Prospective observational study.
RESULTS: Thirty patients were included (three hospitalized), 93% were on HAART, mean CD4(+) cell count was 423 cells/μl and viral load was undetectable in 77% of patients. All patients had fever, 90% had cough, 80% had myalgias, 70% had pharyngeal congestion, 47% had coryza, 47% had odynophagia, 37% had headache and 23% had vomiting. Four patients developed pneumonia. All patients received antiviral therapy and no patient died.
CONCLUSIONS: HIV patients infected by the new influenza A pandemic (H1N1) virus behave similarly to the general population.

Entities:  

Mesh:

Year:  2010        PMID: 20802295     DOI: 10.1097/QAD.0b013e32833e92d5

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  9 in total

1.  Higher antigen content improves the immune response to 2009 H1N1 influenza vaccine in HIV-infected adults: a randomized clinical trial.

Authors:  Hana M El Sahly; Charles Davis; Karen Kotloff; Jeffery Meier; Patricia L Winokur; Anna Wald; Christine Johnston; Sarah L George; Rebecca C Brady; Corinne Lehmann; Abbie Stokes-Riner; Wendy A Keitel
Journal:  J Infect Dis       Date:  2012-01-24       Impact factor: 5.226

Review 2.  Influenza and HIV: lessons from the 2009 H1N1 influenza pandemic.

Authors:  Anandi N Sheth; Pragna Patel; Philip J Peters
Journal:  Curr HIV/AIDS Rep       Date:  2011-09       Impact factor: 5.071

3.  Discovery of anti-influenza nucleoside triphosphates targeting the catalytic site of A/PR/8/34/H1N1 polymerase.

Authors:  Nataraj Sekhar Pagadala; Rakesh Bhat; Jagadeesh Kumar D; Abdolamir Landi
Journal:  Med Chem Res       Date:  2020-05-24       Impact factor: 1.965

4.  Comparison of influenza and SIV specific CD8 T cell responses in macaques.

Authors:  Sinthujan Jegaskanda; Jeanette C Reece; Robert De Rose; John Stambas; Lucy Sullivan; Andrew G Brooks; Stephen J Kent; Amy Sexton
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

5.  Pandemic (H1N1) 2009 and HIV Infection.

Authors:  Shireesha Dhanireddy; Robert D Harrington; Heidi M Crane; Matthew R Gingo; Alison Morris; Laurence Huang; Kristina Crothers
Journal:  Emerg Infect Dis       Date:  2011-06       Impact factor: 6.883

6.  Influenza Vaccination in Identified People Living with HIV/AIDS and Health Care Providers of Triangular Clinics in Iran, 2015-2016.

Authors:  Mohammad Mehdi Gouya; Katayoun Tayeri; Hossein Akbari; Farshid Rezaei; Peyman Hemmati; Mahmood Soroush
Journal:  Iran J Public Health       Date:  2018-02       Impact factor: 1.429

7.  Predictors of mortality in hospitalized children with pandemic H1N1 influenza 2009 in Pune, India.

Authors:  Aarti Avinash Kinikar; Rajesh K Kulkarni; Chhaya T Valvi; Vidya Mave; Nikhil Gupte; Sandhya Khadse; Renu Bhardwaj; Anju Kagal; Shaila Puranik; Amita Gupta; Robert Bollinger; Arun Jamkar
Journal:  Indian J Pediatr       Date:  2011-10-20       Impact factor: 1.967

8.  Higher memory responses in HIV-infected and kidney transplanted patients than in healthy subjects following priming with the pandemic vaccine.

Authors:  Claire-Anne Siegrist; Christian van Delden; Michael Bel; Christophe Combescure; Cécile Delhumeau; Matthias Cavassini; Olivier Clerc; Sara Meier; Karine Hadaya; Paola M Soccal; Sabine Yerly; Laurent Kaiser; Bernard Hirschel; Alexandra Calmy
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

9.  HIV-1 and its gp120 inhibits the influenza A(H1N1)pdm09 life cycle in an IFITM3-dependent fashion.

Authors:  Milene Mesquita; Natalia Fintelman-Rodrigues; Carolina Q Sacramento; Juliana L Abrantes; Eduardo Costa; Jairo R Temerozo; Marilda M Siqueira; Dumith Chequer Bou-Habib; Thiago Moreno L Souza
Journal:  PLoS One       Date:  2014-06-30       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.